Airway protective disorders are a prevalent and progressive consequence of Parkinson's Disease (PD), and often result in aspiration pneumonia which is the leading cause of death in PD. Despite this, a large number of patients with PD do not access specialized services to address these critical deficits. The investigators will examine the comparative effectiveness of a novel treatment paradigm delivered in-person versus via telehealth in persons with PD, as well as the role of patient burden and treatment adherence on outcomes; thus, the proposed research is relevant to public health and in line with NIH's mission to identify novel, efficacious, and accessible rehabilitation strategies for short- and long-term improvement of dysfunctional airway protection in PD.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Peak Expiratory Flow Rate (Cough PEFR) - phase 1
Timeframe: Pretraining to posttraining (after four weeks of intensive training)
Change in Peak Expiratory Flow Rate (Cough PEFR) - phase 2
Timeframe: post-training to post one-year maintenance
Change in Penetration-Aspiration Scale (PAS) - phase 1
Timeframe: Pretraining to posttraining (after four weeks of intensive training)
Change in Penetration-Aspiration Scale (PAS) - phase 2
Timeframe: post-training to post one-year maintenance